Copyright
©2014 Baishideng Publishing Group Inc.
World J Cardiol. Dec 26, 2014; 6(12): 1278-1284
Published online Dec 26, 2014. doi: 10.4330/wjc.v6.i12.1278
Published online Dec 26, 2014. doi: 10.4330/wjc.v6.i12.1278
Table 3 Whipple’s disease related symptoms and outcome after therapy with tumor necrosis factor alpha inhibitor
Sign or symptom1 | Patients (n) |
Total number of severe complications | 49 (1.88 complications per patient) |
Total number of affected patients | 26 out of 41 patients (63%) |
Fever, septic temperatures | 16 |
T. whipplei septicaemia, T. whipplei in blood | 6 |
Pericarditis | 5 |
Endocarditis (many with valve replacement) | 5 |
IRIS | 4 |
Spondylitis (multisegmental) | 4 |
Colitis, fistula, perforation | 4 |
Neurologic symptoms, meningitis | 3 |
Severe skin manifestation | 3 |
Lymphadenopathy | 2 |
Severe eye complications, blindness | 2 |
Ankylosing sacroiliitis | 2 |
Pulmonary hypertension | 1 |
Outcome | |
Severe sequelae or death | 3/19 |
Blindness | 1 |
Neurological symptoms | |
(cognitive sequelae, dysfunction) | 1 |
Death | 1 |
Resolution or favorable outcome | 16/19 |
Not specified/no data | 22 |
- Citation: Marth T. Complicated Whipple’s disease and endocarditis following tumor necrosis factor inhibitors. World J Cardiol 2014; 6(12): 1278-1284
- URL: https://www.wjgnet.com/1949-8462/full/v6/i12/1278.htm
- DOI: https://dx.doi.org/10.4330/wjc.v6.i12.1278